{"entity":{"type":"insider","cik":"0001644489","url":"/insider/0001644489","json_url":"/insider/0001644489.json","name":"Gros David-Alexandre C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2016-02-24","last":"2021-12-21","span_basis":"filed_date"},"name_variants":[{"name":"Gros David-Alexandre C","source":"filing","n_filings":4,"first_seen":"2016-02-24","last_seen":"2021-12-21"}],"transactions":[{"id":5134020,"accession":"0000899243-21-049171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-049171","line_url":"/filing/0000899243-21-049171#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Eledon Pharmaceuticals, Inc.","issuer_ticker":"ELDN","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001644489","owner_name":"Gros David-Alexandre C","owner_display_name":"Gros David-Alexandre C","owner_url":"/insider/0001644489","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.48,"price_display":"4.48","price_state":"stated","total_value":8960.0,"total_display":"8,960.00","total_whole":"8,960","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-21","scope":"insider"},{"id":4573289,"accession":"0001209191-21-052519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052519","line_url":"/filing/0001209191-21-052519#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Eledon Pharmaceuticals, Inc.","issuer_ticker":"ELDN","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001644489","owner_name":"Gros David-Alexandre C","owner_display_name":"Gros David-Alexandre C","owner_url":"/insider/0001644489","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.21,"price_display":"6.21","price_state":"stated","total_value":24840.0,"total_display":"24,840.00","total_whole":"24,840","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":5237264,"accession":"0000899243-21-022998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-022998","line_url":"/filing/0000899243-21-022998#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Eledon Pharmaceuticals, Inc.","issuer_ticker":"ELDN","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001644489","owner_name":"Gros David-Alexandre C","owner_display_name":"Gros David-Alexandre C","owner_url":"/insider/0001644489","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":24030.0,"total_display":"24,030.00","total_whole":"24,030","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":2224364,"accession":"0001553878-16-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-16-000038","line_url":"/filing/0001553878-16-000038","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001644489","owner_name":"Gros David-Alexandre C","owner_display_name":"Gros David-Alexandre C","owner_url":"/insider/0001644489","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":62.749,"price_display":"62.75","price_state":"stated","total_value":62749.0,"total_display":"62,749.00","total_whole":"62,749","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-02-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Eledon Pharmaceuticals, Inc.","url":"/issuer/0001404281","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2021-06-10","last_seen":"2021-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (SVP, Chief Business Officer)","n_filings":1,"first_seen":"2016-02-24","last_seen":"2016-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001644489","retrieved_at":"2026-08-22T07:56:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}